On Saturday, October 19, 2024, Healthy Brains, Healthy Lives (HBHL) presented the second edition of the Amazing Brain Science Talks, organized in collaboration with . Held at the PHI Centre in Montreal, the event was a great success, drawing over 100 members for an engaging afternoon focused on brain health.
$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson鈥檚 disease
REM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What鈥檚 worse, people with the disorder often go on to develop Parkinson鈥檚 disease.
Philippe Gros appointed Chief Scientific Officer of D2R
Philippe Gros has been appointed Chief Scientific Officer (CSO) of 平特五不中鈥檚 DNA to RNA (D2R) Initiative, effective September 30, 2024. Prior to this role, he served as Deputy Vice-President (Research and Innovation) at 平特五不中. This appointment follows a thorough international search, with the selection committee enthusiastic about their recommendation. Notably, Gros was instrumental in writing the application for the D2R Initiative, laying the groundwork for its success.
D2R welcomes RNA and genomic researchers to Universit茅 de Sherbrooke
Montreal 鈥 October 31, 2024 鈥 平特五不中鈥檚 DNA to RNA (D2R) research initiative is proud to announce the appointment of three new researchers at Universit茅 de Sherbrooke, marking the inaugural recipients of the D2R鈥檚 New Faculty Start-Up funding program. Universit茅 de Sherbrooke is a partner institution in the D2R initiative, working collaboratively to advance genomic and RNA research.
$1.14 million from CIHR will resolve treatment roadblocks for rare brain disorders
听
Gene therapy for rare neurological disorders will move one step forward thanks to a $1.14 million grant from the Canadian Institutes of Health Research (CIHR).
Thomas Durcan鈥檚 project will dissect the role of microglia in degenerative conditions, to identify new therapeutic strategies for Alzheimer's treatment
An innovative new program based at The Neuro has received $2.6 million from the CQDM and the Brain Canada Foundation.
MRI data from large sample shows increased whole-brain connectivity in people with a second language
Neuroplasticity is the brain鈥檚 ability to build connections within itself, adapting to the surrounding environment. The brain is most plastic in childhood, forming new pathways in reaction to stimuli such as language.
The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
RNA Nanotechnology - Gordon Research Conference (GRC)
Controlling RNA Sequence for Diagnostics and Therapeutic DeliveryJanuary 5 - 10, 2025
Ventura, California, United States
Scientists use stem cells to follow development of protein bodies characteristic of neurological disease
Congratulations to Dr. Raquel Cuella Martin on receiving the prestigious Gairdner Foundation Early Career Investigator Award.
As an Assistant Professor of Human Genetics at 平特五不中, Dr. Cuella Martin is pushing the boundaries of science with her lab, which uses precision genome editing to tackle complex biological problems.
G茅nome Qu茅bec invests up to $500,000 to boost RNA therapeutics innovation in Quebec
G茅nome Qu茅bec, a private, non-profit organization dedicated to advancing genomics research and innovation in Quebec, is investing up to $500,000 in 平特五不中鈥檚 D2R Initiative. This investment will advance the commercialization of innovative genomic technologies in Quebec through D2R鈥檚 Commercialization Priming funding program.
Join 平特五不中 Health Centre's next 鈥淢edical Genetics Grand Rounds鈥
The founder effect, which is observed in certain regions of Quebec, can increase susceptibility to rare disease. This stems from the fact that these communities were founded by populations that were already related.
D2R awards $7.3 million to Advance Research in Genomic-Based RNA Therapeutics
Montreal 鈥 September 17, 2024听 平特五不中鈥檚 D2R initiative is proud to announce the 23 recipients of its inaugural funding programs, Foundational Projects and Research in Motion. With a total investment of $7.3 million, these awards mark a significant milestone in advancing the field of genomic-based RNA therapeutics.
A recent article in La Presse, , highlights how Quebec's life sciences sector is experiencing a significant revival with the creation of an RNA hub.
Here is a exerpt from the article (translated to english):听